Advancing RSV Maternal Immunization: A Gap Analysis Report
This report describes the evidence and policy needs of global and country decision-makers, public health program planners, and implementers that may be involved in maternal respiratory syncytial virus (RSV) vaccine decisions or delivery. Developed by the Advancing Maternal Immunization collaboration, a group of cross-sectoral experts convened by PATH and the World Health Organization to advance RSV maternal immunization, the report focuses specifically on the context of potential introduction in low- and middle-income countries (LMICs) and summarizes relevant evidence across the following broad topic areas: 1) disease, 2) product, 3) health economics and financing, and 4) vaccine service delivery. Critical gaps in evidence are highlighted that, if left unfilled, could delay or preclude vaccine introduction in LMICs.
Author: Advancing Maternal Immunization collaboration
» Download file (English)
1.6 MB PDF (Located at path.azureedge.net)
Resource types: Report
Diseases/vaccines: Respiratory syncytial virus (RSV)
Topics: Advocacy and communications, Introduction and service delivery, Immunization financing, Organizations and coalitions, Disease burden and surveillance, Vaccine safety and performance, Disease/vaccine specific information, Supply chain and logistics systems